Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04221997 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.

Study acronym: EV-SoPRANO
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 1, 2024 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Sep 2025 to Sep 2026v10
  2. Primary and study completion dates: Sep 2024 to Sep 2025 Study sites: 2 to 1v9 Show 1 more changeShow less
    • Study sites: 2 to 1
  3. Site details revised at 2 of 2 sitesv8
  4. 3 versions Re-verified since Jun 21, 2021, no change to tracked fieldsv5-v7
  5. Trial status: Not Yet Recruiting to Recruiting Study sites: 1 to 2 · Start date changed from estimate of Jan 2020 to Nov 1, 2019v4 Show 2 more changesShow less
    • Study sites: 1 to 2
    • Start date changed from estimate of Jan 2020 to Nov 1, 2019
Show 2 earlier versionsHide 2 earlier versions
  1. Primary endpoint revisedv3 See this version in full on ClinicalTrials.gov ↗
  2. Primary endpoint revised Study title expanded, about 5 wordsv2 Show 1 more changeShow less
    • Study title expanded, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Cincinnati
68 trials monitored
See 6 trials at risk
Anxiety
2,264 trials monitored
See 97 trials at risk
A Multicenter, acute, randomized, double-blind, placebo-controlled, flexible-dose trial with the treatment of sertraline.
Trial Details
NCT Number NCT04221997
Lead Sponsor University of Cincinnati
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Anxiety Disorders
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov